Rosalind Glasspool
University of Utah(US)Beatson West of Scotland Cancer Centre(GB)Huntsman Cancer Institute(US)Cancer Research UK Clinical Trials Unit(GB)Geotechnical Consulting Group (United Kingdom)(GB)University of Glasgow(GB)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments, CRISPR and Genetic Engineering
Most-Cited Works
- → ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease(2019)1,130 cited
- → Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk(2015)906 cited
- → Copy number signatures and mutational processes in ovarian carcinoma(2018)445 cited
- → Epigenetics as a mechanism driving polygenic clinical drug resistance(2006)234 cited
- → Clinical Trials in Recurrent Ovarian Cancer(2011)226 cited
- → Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial(2019)217 cited